FDA approves first postpartum depression drug
For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. The FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts 1 in 9 new mothers after childbirth. CNN's Dr. Sanjay Gupta reports.
02:00 - Source: CNN
Latest Videos 17 videos
postpartum stock 02
FDA approves first postpartum depression drug
02:00
Now playing
- Source: CNN
Former US president Donald Trump at Turnberry golf course, in South Ayrshire, during his visit to the UK on May 2, 2023.
Legal expert explains what it means to get a target letter from DOJ
01:37
Now playing
- Source: CNN
Family trapped in home flood
Military drone video shows family trapped in a Russian controlled village after dam collapse
01:42
Now playing
- Source: CNN
wagner leader Yevgeny Prigozhin
Wagner chief 'certain' Russia will lose territory to Ukraine
00:54
Now playing
- Source: CNN
National Geographic Explorer-in-Residence and leader of the excavation expedition, Lee Berger, inside the last reach out of the chute labyrinth inside the Rising Star cave. Photo Courtesy Lee Berger
Chris Christie blasts Trump during presidential bid announcement
00:48
Now playing
- Source: CNN
New York City air quality Jones pkg
New Yorkers react to smoky skies
01:54
Now playing
- Source: CNN
video thumbnail kate boulduan licht announcement
CNN anchor announces CEO is leaving the network